Target intelligence / Profile preview

Chromosome 19 open reading frame 85 (C19orf85)

Target
C19orf85
Molecular classification
Other (uncharacterized protein; no evidence for classification as enzyme, receptor, transporter, etc.)
01

Overview

Chromosome 19 open reading frame 85 (C19orf85) encodes an uncharacterized human protein currently lacking specific functional, mechanistic, or structural annotation in major biomedical databases. Sequence analysis shows it is 222 amino acids in length. C19orf85 is poorly studied: its function in normal physiology or disease is unknown, and no published data support direct targeting by drugs or therapeutic agents. Proteomic studies suggest C19orf85 expression is sensitive to cellular micronutrient status and diminishes in cells deficient in the metal transporter ZIP8 (SLC39A8), hinting at a role in micronutrient regulation, cellular metal ion homeostasis, or broader metabolic networks[4]. Bioinformatic network prediction implies C19orf85 may be co-expressed or interact with proteins involved in mitosis, cell cycle, and apoptosis—including Aurora kinases and DIABLO—but these are computational predictions without experimental confirmation[1]. It is not classified as a drug target, receptor, enzyme, transporter, or transcription factor, nor is it established as a disease gene or clinical biomarker. Nomenclature is consistent across sources: "Chromosome 19 open reading frame 85" (C19orf85) is the preferred name and abbreviation[1][4][6]. If you need highly structured or canonical information, this target currently lacks the molecular, mechanistic, disease, or pharmacological data seen with common therapeutic proteins.

Other names
C19orf85Uncharacterized protein C19orf85Chromosome 19 open reading frame 85
02

Mechanism of action

null

03

Biological functions

Other (biological function currently uncharacterized; some evidence for association with protein interaction networks and cellular pathways, but no direct functional assignment)[1][4]
04

Disease associations

Other (potential associations inferred by expression changes in certain conditions, such as ZIP8 deficiency and possibly cancer, but no direct disease mechanism or established role)[4]
05

Safety considerations

None reported
06

Interacting drugs

None known
07

Biomarkers

None known

Beyond the preview

Go deeper on Chromosome 19 open reading frame 85 (C19orf85).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chromosome 19 open reading frame 85 (C19orf85).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call